Key facts
- Judge William Young in Boston ruled the administration cannot bar providers from acknowledging patients' gender identity or providing gender-affirming care.
- The conditions were adopted for the Ryan White HIV/AIDS Program, created by Congress in 1990 for low-income and uninsured people with HIV.
- Plaintiffs argued the policy violated the Administrative Procedure Act and conflicted with the program's statutory mandate.
- Plaintiffs also said the conditions discriminated based on transgender status and restricted doctors' speech.
- The administration rejected a settlement proposal from the plaintiffs, according to an October 2 court filing.
A federal judge ruled on Thursday that President Donald Trump's administration cannot bar healthcare providers receiving certain federal HIV-treatment funds from acknowledging the gender identity of their transgender patients or from providing them gender-affirming care.
US District Judge William Young in Boston sided with a group of national HIV medical associations and healthcare providers that challenged grant funding conditions imposed by the administration last year, after Trump signed an executive order prohibiting federal funding for what he calls "gender ideology." Young was appointed by Republican President Ronald Reagan.
The lawsuit was filed in June by groups including the American Academy of HIV Medicine over policies the US Department of Health and Human Services adopted for the Ryan White HIV/AIDS Program, created by Congress in 1990 to provide medical care for low-income and uninsured people living with HIV.
Beginning in March, the Health Resources and Services Administration, a division of HHS that administers the program, added funding conditions designed to implement Trump's executive order directing the US government to recognize only two sexes, male and female. The conditions required providers to ensure funding would support activities using "sex-based definitions grounded in biological reality" and not "social or medical experimentation," according to the lawsuit.
The plaintiffs contended the policy violates the Administrative Procedure Act, which governs how federal agencies make, change and repeal regulations. They said the changes conflicted with the Ryan White Program's statutory mandate to provide comprehensive medical services to HIV patients, which historically has included hormone therapy for transgender people. They also said the conditions violated the Constitution by discriminating based on transgender status and by restricting the speech of doctors who would not be able to refer to patients by their preferred pronouns.
Young had urged the administration at the end of a bench trial in September to settle the case. The administration rejected a settlement proposal from the plaintiffs, according to an October 2 court filing.
The HIV funding policy change was part of Trump's broader crackdown on the rights of transgender people. He has banned transgender people from the military and barred passport applicants from designating their gender identities, actions the US Supreme Court permitted. His administration also has moved to restrict gender-affirming care for transgender inmates in federal prisons and backed state laws banning transgender athletes from female sports teams at public schools including universities.